Inovio Pharmaceuticals, Inc.

INO · NASDAQ
Analyze with AI
9/30/2025
6/30/2025
3/31/2025
12/31/2024
Operating Activities
Net Income-$0-$24-$0-$0
Dep. & Amort.$0$1$0$0
Deferred Tax$0$0$0$0
Stock-Based Comp.$0$1$0$0
Change in WC-$0$0-$0-$0
Other Non-Cash$0$1-$0-$0
Operating Cash Flow-$0-$21-$0-$0
Investing Activities
PP&E Inv.-$0-$0-$0$0
Net Acquisitions$0$0$0$0
Inv. Purchases$0-$5$0$0
Inv. Sales/Matur.$0$11$0$0
Other Inv. Act.$0-$1$0$0
Investing Cash Flow$0$5-$0$0
Financing Activities
Debt Repay.$0$0$0$0
Stock Issued$0$0$0$0
Stock Repurch.$0$0$0$0
Dividends Paid$0$0$0$0
Other Fin. Act.$0-$0-$0$0
Financing Cash Flow$0-$0$0$0
Forex Effect$0$0$0$0
Net Chg. in Cash$0-$16-$0$0
Supplemental Information
Beg. Cash$0$40$0$0
End Cash$0$24$0$0
Free Cash Flow-$0-$21-$0-$0
Inovio Pharmaceuticals, Inc. (INO) Financial Statements & Key Stats | AlphaPilot